A retrospective study to evaluate the virological response to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-positive patients with lamivudine-resistant hepatitis B virus coinfection
Latest Information Update: 27 Jan 2020
At a glance
- Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 27 Jan 2020 New trial record